Stay updated on Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page no longer lists Rheumatoid arthritis and the related MedlinePlus Genetics topic in the topics/links sections. This reduces the presence of RA context and related resources on the study page, potentially affecting findability for RA information.
    Difference
    0.2%
    Check dated 2025-10-27T21:05:47.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    - Added a government operating status notice and reference to NIH Clinical Center operations, plus a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0; removed old v3.1.0.
    Difference
    1%
    Check dated 2025-10-06T08:29:40.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Major updates: add MedlinePlus Arthritis and Genetics topics; remove several drug-safety related topics and old revision; update revision to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-29T05:17:21.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic on Rheumatoid arthritis from the page.
    Difference
    0.1%
    Check dated 2025-09-22T03:09:23.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page updated from Revision v3.0.1 to v3.0.2; the 'Back to Top' link was removed. This appears to be a minor update with no evident changes to core content or key data.
    Difference
    0.1%
    Check dated 2025-09-14T23:10:08.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    The web page has been updated to include a new research article on the safety profile of Upadacitinib, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    1%
    Check dated 2025-09-07T19:43:58.000Z thumbnail image

Stay in the know with updates to Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.